×

CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2019.07.014
Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors
Shin1, SJ; Kim, T; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI; Kang, M

INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.6.454
The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy
Song1, W; Kang, M; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG

J ENDOUROL 2019 10.1089/end.2019.0410
Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors
Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI

UROL INT 2019 10.1159/000501527
Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy
Lee1, CU; Sung, SH; Jang, CT; Kang, M; Sung, HH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Jeon, HG

CANCER RES TREAT 2019 10.4143/crt.2018.604
Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study
Hur1, JY; Kim, Y; Kwon, GY; Kang, M; Sung, HH; Jean, HG; Jeong, BC; Seo, SI; Jean, SS; Lee, HM; Lee, SJ; Park, SH

WORLD J UROL 2019 10.1007/s00345-018-02617-2
Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer
Choi1, YH; Yu, JW; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG

CUAJ-CAN UROL ASSOC 2019 10.5489/cuaj.5605
Detection of circulating tumor cells and their potential use as a biomarker for advanced renal cell carcinoma
Kim1, TH; Kang, YT; Cho, YH; Kim, JH; Jeong, BC; Seo, SL; Jeon, SS; Lee, HM

APPL SCI-BASEL 2019 10.3390/app9152982
PROMISE CLIP Project: A Retrospective, Multicenter Study for Prostate Cancer that Integrates Clinical, Imaging and Pathology Data
Park1, J; Rho, MJ; Park, YH; Jung, CK; Chong, Y; Kim, CS; Go, H; Jeon, SS; Kang, M; Lee, HJ; Hwang, SI; Lee, JY

INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.4.227
Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing
Kang1, M; Cho, E; Jang, J; Lee, J; Jeon, Y; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG

INT J SURG 2019 10.1016/j.ijsu.2019.04.013
Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study
Song1, W; Jeong, JY; Jeon, HG; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Sung, HH

BMC UROL 2019 10.1186/s12894-019-0463-7
A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer
Yoon1, SE; Kim, Y; Cho, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Lee, SJ; Park, SH

PROSTATE 2019 10.1002/pros.23766
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation
Choi1, YH; Han, DH; Kim, SW; Kim, MJ; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY

Cancer Manag Res 2019 10.2147/CMAR.S199432
Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion
Lee1, CU; Kang, M; Kim, TJ; Na, JP; Sung, HH; Jeon, HG; Seo, S; Jeon, SS; Lee, HM; Jeong, BC

SCI REP-UK 2019 10.1038/s41598-019-42739-0
Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma
Kim1, TH; Suh, YS; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Sung, HH

PROSTATE CANCER P D 2019 10.1038/s41391-018-0088-z
Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data
Jeong1, CW; Kang, M; Jung, SI; Kim, TH; Park, SW; Joung, JY; Jeon, SS; Hong, JH; Lee, JY; Chung, BH; Ahn, H; Kim, CS; Kwon, DD; Kwak, C

CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2018.09.007
Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis
Choi1, YH; Kang, MY; Sung, HH; Eon, HG; Jeong, BC; Seo, SI; Jeon, SS; Kim, CK; Park, BK; Lee, HM

KOREAN J RADIOL 2019 10.3348/kjr.2018.0613
Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2
Kim1, R; Kim, CK; Park, JJ; Kim, JH; Seo, SI; Jeon, SS; Lee, HM

DIAGN PATHOL 2019 10.1186/s13000-019-0782-8
Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy
Choi1, YH; Yu, JW; Jeong, BC; Seo, S; Jeon, SS; Lee, HM; Jeon, HG

Cancer Manag Res 2019 10.2147/CMAR.S185796
Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients
Yu1, J; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH

SCI REP-UK 2019 10.1038/s41598-018-36602-x
Establishment and Validation of Extra-transitional Zone Prostate Specific Antigen Density (ETzD), a Novel Structure-based Parameter for Quantifying the Oncological Hazard of Prostates with Enlarged Stroma
Kim1, JJ; Suh, YS; Kim, TH; Jeon, SS; Lee, HM; Choi, H; Kim, S; Lee, KS